Parallel Trade in Polish Pharma: The Good and the Bad
Poland’s entrance into the EU has been a catalyst for growth that has allowed the country to flourish, shown by the nation’s ranking as the eighth largest economy in Europe according…
Address: ul. A & F Radziwill 9 , 05-850 Ozarow
Tel: (4822) 679-51-35
Web: http://www.vipharm.com.pl/
Vipharm S.A. is a Polish pharmaceutical company focusing for last 10 years on research, production and sale of specialist drugs.
Our drugs meet the requirements of Good Manufaktury Practice and Good Distribution Practice.
Safety and efficacy of our drugs has been confirmed by bioequivalence and bioavailability studies.
Vipharm S.A. still obtains excellent economical results, and is a successful competitor of the biggest manufacturers of medicines both on Polish and foreign markets. It has a leading position in respect of the value of sale and the amount of sold packages on Polish pharmaceutical market.
High quality of our drugs has been distinguished with Certificate of Innovation 2005 from PolishAcademy of Science and since 2008 year by year Vipharm S.A. has been distinguished with Certificate of Quality from PolishCenter of Research and Certification .
Scientific research over medicines investing after 10 years of activities in 2008 Vipharm started activity on international markets, on the territory of Czech, Slovakia, Hungary and Germany create trade companies Vipharm Slovakia s.r.o. Vipharm Hungary Kft. and Vipharm GmbH.
Vipharm S.A. specializing in the development, manufacturing and marketing of branded equivalents that help improve the quality of human life. As a manufacturer of medicines, it offers unique products, manufactured in modern, friendly area, according to GMP rules and the requirements of worldwide pharmacopoeias.
Our offer covers a wide range of therapeutic areas. However, we mainly concentrate on the therapy of Oncology and Central Nervous System diseases.
Poland’s entrance into the EU has been a catalyst for growth that has allowed the country to flourish, shown by the nation’s ranking as the eighth largest economy in Europe according…
“Cost containment measures are not just a Polish story, but a European reality,” says Marcin Hanczaruk, general manager at Amgen. “The Reimbursement Act is a real revolution, but it has…
The general director of Actavis Poland talks about competing in an intense generics market, and the company’s potential in Poland given the country’s 2012 Reimbursement Act. The year 2012 was…
AstraZeneca’s General Manager in Poland discuses AstraZeneca’s strategic realignment to become a highly specialized biotech company after 20 years of presence in Poland. He stresses the importance of the affiliate’s…
Novascon Pharmaceuticals is the second fastest growing company in the OTC/dietary supplement market in Poland. Its founder shares the reasons behind this success, including his strategy to sell their main…
Omega Pharma is a pharmacist champion and one of the fastest growing OTC companies in Poland. Its General Manager in Poland discusses the shift taking place with Pharmacies now becoming…
Schulke Poland’s General Manager wants the affiliate: “to be recognized as a high quality “one stop shop” for hygiene and disinfection. He also comments: “Poland is quite advanced in terms…
The department of innovation and industry under the Ministry of Economy has been preparing a new project called: “Pharmaceutical Industry Mapping.” Its leader hopes: “that the outcome of this exercise…
Bristol-Myers Squibb’s General Manager in Poland stresses the urgent need to allow more innovative drugs to fight against deadly diseases, especially in the field of immune-oncology which he says will:…
Unipharm Poland’s country manager explains what is needed to become a successful OTC and dietary supplement company in Poland, saying that it is “key to master the marketing mix but…
Budget limitations in the Polish vaccine field are a handicap to improving patients’ lives as Sanofi Pasteur General Manager comments: “the National Health Fund’s budget for reimbursement is around EUR…
“Innovation is about bringing new chemical compounds on the market; but it is also, and sometimes even more, to continue the therapeutic development of the drugs which are already there”…
See our Cookie Privacy Policy Here